Virtual conference

Don’t miss the MedCity INVEST PharmaTech virtual conference on July 26

The MedCity INVEST PharmaTech The virtual conference scheduled for Tuesday, July 26 will highlight the many ways pharmaceutical companies are using digital health technologies to support many aspects of their work. Among these applications are AI to identify targets for drug development, the future of digital medicines, the impact of Covid-19 on clinical trials, and more.

Here is an overview of what virtual conferencing has to offer. You can access the full agenda here.

The future of digital medicines (Sponsored by Emerg)
The digital medicine landscape is very promising, although it has so far been a story of failure. Yet a new generation of companies is aiming to transform the digital therapeutics market. Learn from experts in pharma, digital health, and marketing.

Moderator: Carrie Northcott, Senior Director, Digital Medicine and Translational Imaging Project Manager, Pfizer


  • Lana Ghanem, Managing Director, Hikma Ventures
  • Pierre Leurent, President, Digital Health, Aptar Pharma
  • Mario Moreira, Senior Consultant, Emergn
  • Abhishek Shah, Co-Founder and CEO, Wellthy Therapeutics

Pharma + Digital: Here’s how to make it a heavenly wedding
To say that the culture of the pharmaceutical and health technology worlds is different is an understatement. But they each have elements that the other needs. What are the strategies for better alignment and partnerships.

Moderator: Naomi Fried, CEO and Founder, Pharmstars


  • Jessica Federer, Partner, Boston Millennia Partners
  • Charles Fisher, Founder and CEO, Unlearn.AI
  • Joel Krikston, Managing Director of Venture Capital Investments and Head of Strategic Innovation Alliances, Merck Global Health Innovation Fund
  • Jim Parshall, Senior Director – External Innovation in Health and Connected Devices, Eli Lilly and Company

The state of AI in drug discovery
Artificial intelligence in healthcare is finally emerging from being overhyped to show practical applications. If he succeeds in the field of drug discovery, it will be a monumental achievement that will help to both speed up and reduce the cost of drug development. Learn from experts where we stand in effectively using AI for drug discovery.

Moderator: Frank Vinluan, senior biopharmaceutical reporter, MedCity News


  • Nathan Benaich, Founder and General Partner, Air Street Capital
  • Chris Gibson, Co-Founder and CEO, Recursion
  • Najat Khan, Head of Data Science, Global Head, Strategy and Operations, Janssen Pharmaceuticals
  • Richard Law, Commercial Director, Exscientia

The day’s roundtables will culminate with the Pitch Perfect competition featuring five companies seeking to reinvent clinical trials with different approaches. The contest judges include:

  • Cris De Luca, Partner, Digital, Sanofi Ventures
  • Jessica Federer, Partner, Boston Millennia Partners
  • Joel Krikston, Managing Director of Venture Capital Investments and Head of Strategic Innovation Alliances, Merck Global Health Innovation Fund
  • Maxim Owen, Venture Capital Partner, Wavemaker Three-Sixty Health

To discover the competing startups, click here.

Photo: Who_I_am, Getty Images